SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SelectMDx and Multiparametric Magnetic Resonance Imaging of the Prostate for Men Undergoing Primary Prostate Biopsy: A Prospective Assessment in a Multi-Institutional Study
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 9, Pages 2047
Publisher
MDPI AG
Online
2021-04-24
DOI
10.3390/cancers13092047
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of uni- or multifocal perineural invasion in prostate cancer at radical prostatectomy
- (2021) Alessandro Sciarra et al. Translational Andrology and Urology
- Untargeted metabolomics of prostate cancer zwitterionic and positively charged compounds in urine
- (2021) Andrea Cerrato et al. ANALYTICA CHIMICA ACTA
- The Clinical Efficacy of Nitrofurantoin for Treating Uncomplicated Urinary Tract Infection in Adults: A Systematic Review of Randomized Control Trials
- (2021) Angelo Porreca et al. UROLOGIA INTERNATIONALIS
- Assessment of PSIM (Prostatic Systemic Inflammatory Markers) Score in Predicting Pathologic Features at Robotic Radical Prostatectomy in Patients with Low-Risk Prostate Cancer Who Met the Inclusion Criteria for Active Surveillance
- (2021) Matteo Ferro et al. Diagnostics
- Validation of a 2‐gene mRNA urine test for the detection of ≥GG2 prostate cancer in an opportunistic screening population
- (2020) Jose Rubio‐Briones et al. PROSTATE
- Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy
- (2020) Gian Maria Busetto et al. WORLD JOURNAL OF UROLOGY
- Clinical Utility of 4Kscore, ExosomeDx and Magnetic Resonance Imaging for the Early Detection of High-Grade Prostate Cancer
- (2020) Claire M. de la Calle et al. JOURNAL OF UROLOGY
- Cribriform pattern does not have a significant impact in Gleason Score ≥7/ISUP Grade ≥2 prostate cancers submitted to radical prostatectomy
- (2020) Simone Flammia et al. MEDICINE
- EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2020) Nicolas Mottet et al. EUROPEAN UROLOGY
- The State of the Science on Prostate Cancer Biomarkers: The San Francisco Consensus Statement
- (2019) Matthew R. Cooperberg et al. EUROPEAN UROLOGY
- Multicenter Optimization and Validation of a 2-Gene mRNA Urine Test for Detection of Clinically Significant Prostate Cancer Prior to Initial Prostate Biopsy
- (2019) Alexander Haese et al. JOURNAL OF UROLOGY
- Androgen receptor variant 7 (AR-V7) in sequencing therapeutic agents for castratrion resistant prostate cancer
- (2019) Alessandro Sciarra et al. MEDICINE
- Plasmatic exosomes from prostate cancer patients show increased carbonic anhydrase IX expression and activity and low pH
- (2019) Mariantonia Logozzi et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Prostate Imaging Reporting and Data System 3 Category Cases at Multiparametric Magnetic Resonance for Prostate Cancer: A Systematic Review and Meta-analysis
- (2019) Martina Maggi et al. European Urology Focus
- Incorporating biomarkers into the primary prostate biopsy setting: a cost-effectiveness analysis
- (2018) Niranjan J. Sathianathen et al. JOURNAL OF UROLOGY
- MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
- (2018) Veeru Kasivisvanathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness of SelectMDx for prostate cancer in four European countries: a comparative modeling study
- (2018) Tim M. Govers et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Psychological impact of different primary treatments for prostate cancer: A critical analysis
- (2018) Martina Maggi et al. ANDROLOGIA
- A urinary biomarker-based risk score correlates with multiparametric MRI for prostate cancer detection
- (2017) Rianne J. Hendriks et al. PROSTATE
- Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score
- (2016) Leander Van Neste et al. EUROPEAN UROLOGY
- A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort
- (2016) Katharina Braun et al. EUROPEAN UROLOGY
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
- (2016) Jeffrey C. Weinreb et al. EUROPEAN UROLOGY
- Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis
- (2016) Shuang G Zhao et al. LANCET ONCOLOGY
- Clinical Utility of Biomarkers in Localized Prostate Cancer
- (2016) Michael S. Leapman et al. Current Oncology Reports
- The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
- (2015) Jonathan I. Epstein et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Short-term pretreatment with a dual 5α-reductase inhibitor before bipolar transurethral resection of the prostate (B-TURP): evaluation of prostate vascularity and decreased surgical blood loss in large prostates
- (2015) Gian Maria Busetto et al. BJU INTERNATIONAL
- The percentage of prostate-specific antigen (PSA) isoform [-2]proPSA and the Prostate Health Index improve the diagnostic accuracy for clinically relevant prostate cancer at initial and repeat biopsy compared with total PSA and percentage free PSA in men
- (2015) Martin Boegemann et al. BJU INTERNATIONAL
- Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer
- (2015) G. H. J. M. Leyten et al. CLINICAL CANCER RESEARCH
- Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer
- (2015) Tobias Nordström et al. EUROPEAN UROLOGY
- The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
- (2015) Stacy Loeb et al. JOURNAL OF UROLOGY
- Multiparametric magnetic resonance imaging vs. standard care in men being evaluated for prostate cancer: A randomized study
- (2015) Valeria Panebianco et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- A 17-gene Assay to Predict Prostate Cancer Aggressiveness in the Context of Gleason Grade Heterogeneity, Tumor Multifocality, and Biopsy Undersampling
- (2014) Eric A. Klein et al. EUROPEAN UROLOGY
- Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®)
- (2014) Gian Maria Busetto et al. BMC Urology
- Clinical utility of the prostate cancer gene 3 (PCA3) urine assay in Japanese men undergoing prostate biopsy
- (2013) Atsushi Ochiai et al. BJU INTERNATIONAL
- Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy Cohort
- (2013) Matthew R. Cooperberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy
- (2013) Vincenzo Scattoni et al. JOURNAL OF UROLOGY
- Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy
- (2013) Nicholas Erho et al. PLoS One
- Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) Significantly Improve Prostate Cancer Detection at Initial Biopsy in a Total PSA Range of 2–10 ng/ml
- (2013) Matteo Ferro et al. PLoS One
- Comparative Assessment of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG Gene Fusion with the Serum [-2]Proprostate-Specific Antigen-Based Prostate Health Index for Detection of Prostate Cancer
- (2012) C. Stephan et al. CLINICAL CHEMISTRY
- Prospective Multicentre Evaluation of PCA3 and TMPRSS2-ERG Gene Fusions as Diagnostic and Prognostic Urinary Biomarkers for Prostate Cancer
- (2012) Gisele H.J.M. Leyten et al. EUROPEAN UROLOGY
- Clinical Utility of an Epigenetic Assay to Detect Occult Prostate Cancer in Histopathologically Negative Biopsies: Results of the MATLOC Study
- (2012) Grant D. Stewart et al. JOURNAL OF UROLOGY
- A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy
- (2011) Marco Auprich et al. BJU INTERNATIONAL
- A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
- (2011) William J. Catalona et al. JOURNAL OF UROLOGY
- Utility of PCA3 in patients undergoing repeat biopsy for prostate cancer
- (2011) A K Wu et al. PROSTATE CANCER AND PROSTATIC DISEASES
- A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands
- (2010) A Gupta et al. BRITISH JOURNAL OF CANCER
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
- (2009) G. Draisma et al. JNCI-Journal of the National Cancer Institute
- A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
- (2008) Andrew J Vickers et al. BMC Medicine
- Clinical Utility of the PCA3 Urine Assay in European Men Scheduled for Repeat Biopsy
- (2008) Alexander Haese et al. EUROPEAN UROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now